Given the need to improve the efficacy of standard-of-care immunotherapy (anti-CTLA-4 + anti-PD-1) in human malignant pleural mesothelioma (hMPM), we thoroughly characterized the immunobiology of the

NIAID Data Ecosystem20

Characteristics of six patients who required operation.

资源简介：

相关数据集